Merck Healthcare Kgaa is an API and finished-dose manufacturer based in Germany. It holds one active US drug master file. Its filings concentrate with EMA, AEMPS (ES) and INVIMA (CO). Its GMP standing is certified by ZLG (DE), ANVISA (Brazil) and MFDS (Korea), among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 13 May 2022 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Darmstadt, United Arab Emirates | Not on file |
| DARMSTADT, Germany | Not on file |
| Germany, Germany | 3016570199 |
| Frankfurter Strasse Darmstadt Germany, Nigeria | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Cetrorelix | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | 22 | 1 |
| AEMPS (ES) | 20 | None |
| INVIMA (CO) | 16 | None |
| NAFDAC (NG) | 11 | 2 |
| SFDA (Saudi Arabia) | 9 | None |
| UZPHARM (UZ) | 9 | None |
| ZLG (DE) | None | 4 |
| ANVISA (Brazil) | None | 2 |
| MFDS (Korea) | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Merck Healthcare Kgaa, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.